Skip to main content
PMC home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;31(9):601–605. [Article in Spanish] doi: 10.1016/S0212-6567(03)79223-3

Vacunas combinadas (II)

J Puig-Barberà a,*, J Díez Domingo b
PMCID: PMC7681900  PMID: 12783751

The content is available as a PDF (115.5 KB).

Bibliografía

  • 1.Calendarios de vacunación españoles [en línea]. Página web de la Asociación Española de Pediatría de Atención Primaria [última actualización] 3 Jan 2002. Asociación Española de Pediatría de Atención Primaria. Consultado el 1 de abril de 2002. Disponible en: www.aepap.org/bajables/calvaces2002.pdf
  • 2.Weniger B.G., Chen R.T., Jacobson S.H., Sewell E.C., Deuson R., Livengood J.R. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine. 1998;16:1885–1897. doi: 10.1016/s0264-410x(98)00170-4. [DOI] [PubMed] [Google Scholar]
  • 3.Le C.T. Combination vaccines: choices or chaos? A practitioner’s perspective. Clin Infect Dis. 2001;33(Suppl 4):S367–S371. doi: 10.1086/322575. [DOI] [PubMed] [Google Scholar]
  • 4.Woodin K.A., Rodewald L.E., Humiston S.G., Carges M.S., Schaffer S.J., Szilagyi P.G. Physician and parent opinions. Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med. 1995;149:845–849. doi: 10.1001/archpedi.1995.02170210019003. [DOI] [PubMed] [Google Scholar]
  • 5.Eskola J., Ward J., Dagan R., Goldblatt D., Zepp F., Siegrist C.A. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet. 1999;354:2063–2068. doi: 10.1016/S0140-6736(99)04377-9. [DOI] [PubMed] [Google Scholar]
  • 6.Zepp F., Schmitt H.J., Kaufhold A., Schuind A., Knuf M., Habermehl P. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr. 1997;156:18–24. doi: 10.1007/s004310050544. [DOI] [PubMed] [Google Scholar]
  • 7.Schmitt H.J., von Kries R., Hassenpflug B., Hermann M., Siedler A., Niessing W. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Pediatr Infect Dis J. 2001;20:767–774. doi: 10.1097/00006454-200108000-00010. [DOI] [PubMed] [Google Scholar]
  • 8.Los Ríos M.R., García M.N., Sanz M.J., Ballester O.E. Parotiditis en un área urbana de la Comunidad de Madrid. Estado vacunal, diagnóstico y medidas de intervención. Aten Primaria. 2001;28:10–16. doi: 10.1016/S0212-6567(01)78889-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Reuman P.D., Sawyer M.H., Kuter B.J., Matthews H. Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group. Pediatr Infect Dis J. 1997;16:662–667. doi: 10.1097/00006454-199707000-00008. [DOI] [PubMed] [Google Scholar]
  • 10.Watson B.M., Laufer D.S., Kuter B.J., Staehle B., White C.J., Starr S.E. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children [published erratum appears in J Infect Dis 1996;173:1529] J Infect Dis. 1996;173:731–734. doi: 10.1093/infdis/173.3.731. [DOI] [PubMed] [Google Scholar]
  • 11.Vesikari T., Ohrling A., Baer M., Delem A., Bogaerts H., Andre F.E. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13–17-month-old children. Acta Paediatr Scand. 1991;80:1051–1057. doi: 10.1111/j.1651-2227.1991.tb11782.x. [DOI] [PubMed] [Google Scholar]
  • 12.Shinefield H.R., Black S.B., Staehle B.O., Matthews H., Adelman T., Ensor K. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogeni-city, persistence of antibody and duration of protection against varicella in healthy children. Pediatr Infect Dis J. 2002;21:555–561. doi: 10.1097/00006454-200206000-00014. [DOI] [PubMed] [Google Scholar]
  • 13.Bryan J.P., Henry C.H., Hoffman A.G., South-Paul J.E., Smith J.A., Cruess D. Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines. Vaccine. 2000;19:743–750. doi: 10.1016/s0264-410x(00)00301-7. [DOI] [PubMed] [Google Scholar]
  • 14.Greenberg D.P., Vadheim C.M., Wong V.K., Marcy S.M., Partridge S., Greene T. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age. Pediatr Infect Dis J. 1996;15:590–596. doi: 10.1097/00006454-199607000-00006. [DOI] [PubMed] [Google Scholar]
  • 15.Treadwell T.L., Keeffe E.B., Lake J., Read A., Friedman L.S., Goldman I.S. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med. 1993;95:584–588. doi: 10.1016/0002-9343(93)90353-q. [DOI] [PubMed] [Google Scholar]
  • 16.Anderson E.L., Decker M.D., Englund J.A., Edwards K.M., Anderson P., McInnes Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA. 1995;273:849–853. [PubMed] [Google Scholar]
  • 17.Greenberg D.P., Pickering L.K., Senders S.D., Bissey J.D., Howard R.A., Blatter M.M. Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy. Pediatrics. 2002;109:666–672. doi: 10.1542/peds.109.4.666. [DOI] [PubMed] [Google Scholar]
  • 18.Combination vaccines for childhood immunization. MMWR Recomm Rep. 1999;48:1–14. [PubMed] [Google Scholar]
  • 19.Jacobs R.L., Lowe R.S., Lanier B.Q. Adverse reactions to tetanus toxoid. JAMA. 1982;247:40–42. [PubMed] [Google Scholar]
  • 20.Kavukcu S., Soylu A., Sarioglu S., Turkmen M., Kupelioglu A., Pekcetin C. IgA nephropathy in mice following repeated administration of conjugated Haemophilus influenzae type B vaccine (PRP-T) Tokai J Exp Clin Med. 1997;22:167–174. [PubMed] [Google Scholar]
  • 21.Baraff L.J., Cody C.L., Cherry J.D. DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics. 1984;73:31–36. [PubMed] [Google Scholar]
  • 22.Jones A.E., Melville-Smith M., Watkins J., Seagroatt V., Rice L., Sheffield F. Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines. Community Med. 1985;7:99–106. doi: 10.1093/oxfordjournals.pubmed.a043782. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES